INDP   $3.55  -9.67% Market Closed After Close 3.7494 5.62%

Indaptus Therapeutics, Inc.
Total Cash 7.30M
totalCashPerShare 0.716
EBITDA -16.48M
Total Debt 130.80K
quickRatio 3.787
currentRatio 3.884
Total Revenue
debtToEquity 2.121
Revenue/Share
ROA -0.71116996
ROE -1.27035
grossProfits
freeCashflow -7.41M
operatingCashflow -12.75M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 4.66M
forwardPE -0.8345324
floatShares 7.48M
sharesOutstanding 10.20M
sharesShort 30.93K
sharesShortPriorMonth 8.90K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.27%
heldPercentInstitutions 0.06%
Short Ratio help_outline 1.32%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 0.721
Price To Book help_outline 1.61
earningsQuarterlyGrowth
netIncomeToCommon -15.75M
trailingEps -1.88%
forwardEps -1.39%
enterpriseToEbitda -0.28
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.47 3Q 2024
institutionsCount 21
lastUpdated Nov. 7, 2024, 5:13 a.m.